The enteric nervous system of P2Y13 receptor null mice is resistant against high-fat-diet- and palmitic-acid-induced neuronal loss

[1]  B. Olde,et al.  Enteric Neuropathy Can Be Induced by High Fat Diet In Vivo and Palmitic Acid Exposure In Vitro , 2013, PloS one.

[2]  C. Pellegrini,et al.  The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications. , 2013, Pharmacology & therapeutics.

[3]  G. Burnstock,et al.  Purinergic signalling and diabetes , 2013, Purinergic Signalling.

[4]  L. Martinez,et al.  Chronic pharmacological activation of P2Y13 receptor in mice decreases HDL-cholesterol level by increasing hepatic HDL uptake and bile acid secretion. , 2013, Biochimica et biophysica acta.

[5]  B. Ohlsson,et al.  Gonadotropin-releasing hormone analog buserelin causes neuronal loss in rat gastrointestinal tract , 2013, Cell and Tissue Research.

[6]  H. Yamanaka,et al.  Multiple P2Y subtypes in spinal microglia are involved in neuropathic pain after peripheral nerve injury , 2012, Glia.

[7]  M. Tsukimoto,et al.  Involvement of P2Y13 receptor in suppression of neuronal differentiation , 2012, Neuroscience Letters.

[8]  P. Hellström,et al.  Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide are neuroprotective on cultured and mast cell co-cultured rat myenteric neurons , 2012, BMC Gastroenterology.

[9]  J. Garrido,et al.  Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation , 2012, Journal of Cell Science.

[10]  K. Jacobson,et al.  P2Y(13) receptor is responsible for ADP-mediated degranulation in RBL-2H3 rat mast cells. , 2010, Pharmacological research.

[11]  M. Champy,et al.  Altered lipoprotein metabolism in P2Y(13) knockout mice. , 2010, Biochimica et biophysica acta.

[12]  L. Martinez,et al.  P2Y13 receptor is critical for reverse cholesterol transport , 2010, Hepatology.

[13]  A. I. Rojo,et al.  The purinergic P2Y(13) receptor activates the Nrf2/HO-1 axis and protects against oxidative stress-induced neuronal death. , 2010, Free radical biology & medicine.

[14]  B. Olde,et al.  ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice , 2010, Diabetologia.

[15]  D. Molliver,et al.  Gi- and Gq-coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior , 2010, Molecular pain.

[16]  A. Adam,et al.  Kinin B1 receptors contributes to acute pain following minor surgery in humans , 2010, Molecular pain.

[17]  J. Fahrenkrug,et al.  Signaling pathways in PACAP regulation of VIP gene expression in human neuroblastoma cells , 2009, Neuropeptides.

[18]  G. Burnstock,et al.  Purinergic signalling in autonomic control , 2009, Trends in Neurosciences.

[19]  E. Ekblad,et al.  Mast cells reduce survival of myenteric neurons in culture , 2009, Neuropharmacology.

[20]  Geoffrey Burnstock,et al.  Purinergic signalling in the nervous system: an overview , 2009, Trends in Neurosciences.

[21]  L. Martinez,et al.  The nucleotide receptor P2Y13 is a key regulator of hepatic High-Density Lipoprotein (HDL) endocytosis , 2005, Cellular and Molecular Life Sciences CMLS.

[22]  E. Ekblad,et al.  Increased expression of nitric oxide synthase in cultured neurons from adult rat colonic submucous ganglia , 2004, Autonomic Neuroscience.

[23]  R. Brommage.  Validation and calibration of DEXA body composition in mice. , 2003, American journal of physiology. Endocrinology and metabolism.

[24]  E. Ekblad,et al.  Increased expression of vasoactive intestinal polypeptide in cultured myenteric neurons from adult rat small intestine , 2003, Autonomic Neuroscience.

[25]  E. Ekblad,et al.  Vasoactive intestinal peptide and nitric oxide promote survival of adult rat myenteric neurons in culture , 2003, Journal of neuroscience research.

[26]  M. Horowitz,et al.  Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. , 2001, Archives of internal medicine.

[27]  K. Mcquaid,et al.  Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life. , 2000, Digestive diseases and sciences.

[28]  G. Tougas,et al.  Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study , 1999, American Journal of Gastroenterology.

[29]  G. Burnstock,et al.  Purinergic signalling: pathophysiological roles. , 1998, Japanese journal of pharmacology.

[30]  H. Young,et al.  Transient expression of neuronal nitric oxide synthase by neurons of the submucous plexus of the mouse small intestine , 1998, Cell and Tissue Research.

[31]  H. Zimmermann.  BIOCHEMISTRY, LOCALIZATION AND FUNCTIONAL ROLES OF ECTO-NUCLEOTIDASES IN THE NERVOUS SYSTEM , 1996, Progress in Neurobiology.

[32]  F. Sundler,et al.  Vasoactive intestinal peptide expression in enteric neurons is upregulated by both colchicine and axotomy , 1996, Regulatory Peptides.

[33]  G. Burnstock,et al.  Neurite outgrowth of striatal neurons in vitro: involvement of purines in the growth-promoting effect of myenteric plexus explants , 1996, International Journal of Developmental Neuroscience.

[34]  F. Sundler,et al.  Distribution, origin and projections of nitric oxide synthase-containing neurons in gut and pancreas , 1994, Neuroscience.

[35]  P. Tso,et al.  Jejunal mucosal injury and restitution: role of hydrolytic products of food digestion. , 1991, The American journal of physiology.

[36]  F. Sundler,et al.  Projections of peptide-containing neurons in rat colon , 1988, Neuroscience.

[37]  G. Burnstock,et al.  Direct evidence for ATP release from non-adrenergic, non-cholinergic ("purinergic") nerves in the guinea-pig taenia coli and bladder. , 1978, European journal of pharmacology.

[38]  G. Burnstock,et al.  Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non‐adrenergic inhibitory nerves in the gut , 1997, British journal of pharmacology.

[39]  G. Burnstock,et al.  Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non‐adrenergic inhibitory nerves in the gut , 1970, British journal of pharmacology.